Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03071094 |
|---|---|
| Brief Title: | A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC) |
| First Submitted : | February 10, 2017 |
| First Submitted that Met QC Criteria : | February 28, 2017 |
| First Posted : | March 6, 2017 |
| Last Update Submitted that Met QC Criteria : | March 11, 2020 |
| Last Update Posted : | March 12, 2020 |